Mixed connective tissue disease: what is behind the curtain?
Authors:
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 21 (6) , 1037-1049
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 2007
- DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti–topoisomerase I autoantibodies from systemic sclerosis patientsArthritis & Rheumatism, 2006
- Transverse myelitis, a rare neurological manifestation of mixed connective tissue disease—a case report and a review of literatureClinical Rheumatology, 2006
- Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD)Rheumatology, 2005
- Direct binding of anti–DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosisArthritis & Rheumatism, 2004
- Difference in HLA‐linked genetic background between mixed connective tissue disease and systemic lupus erythematosusTissue Antigens, 1993
- Prostaglandin infusion therapy for intermittent digital ischemia in a patient with mixed connective tissue diseaseJournal of the American Academy of Dermatology, 1989
- Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.Annals of the Rheumatic Diseases, 1977
- Characteristics of patients with serum antibodies to extractable nuclear antigensArthritis & Rheumatism, 1976
- Antibodies to components of extractable nuclear antigen. Clinical characteristics of patientsArchives of internal medicine (1960), 1976